Debt (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 | |||||||||||||||||||||||||||||
| Debt Instrument [Line Items] | |||||||||||||||||||||||||||||
| Schedule of the Tranche B Note | The following table provides a summary of the changes in the balance and the estimated fair value of the Tranche B Notes (in thousands):
|
||||||||||||||||||||||||||||
| Schedule of revenue liability activity | The following table summarizes the purchased revenue liability activity related to ZTlido Royalty Purchase Agreement during the six months ended June 30, 2026 (in thousands):
June 30,
2026
Ending Balance as of December 31, 2025 $ 2,300
Repayment of purchased revenue liability $ (44 ) Change in fair value of purchased revenue liability
167
Ending Balance as of June 30, 2026 $ 2,423 |
||||||||||||||||||||||||||||
| Oramed Note [Member] | |||||||||||||||||||||||||||||
| Debt Instrument [Line Items] | |||||||||||||||||||||||||||||
| Schedule of the Oramed Note | The following table provides a summary of the changes in the balance and the estimated fair value of the Oramed Note (in thousands):
|
||||||||||||||||||||||||||||